How Chronic Morphine Use Rewires the Brain's Own Opioid Systems
Chronic morphine increased dynorphin in the addiction-related nucleus accumbens and altered enkephalin levels across brain regions, with distinct patterns during withdrawal.
Quick Facts
What This Study Found
Chronic morphine increased dynorphin A and B in the nucleus accumbens and met-enkephalin in the striatum, with distinct withdrawal-phase patterns across brain regions.
Key Numbers
How They Did This
Male Sprague-Dawley rats received twice-daily morphine injections for 8 days. Opioid peptide levels were measured in multiple brain regions and pituitary by radioimmunoassay during treatment and withdrawal.
Why This Research Matters
Changes in endogenous opioid peptides during morphine use and withdrawal help explain tolerance, dependence, and the difficulty of quitting opioids. The nucleus accumbens changes are particularly relevant to addiction.
The Bigger Picture
The nucleus accumbens is central to addiction. Rising dynorphin there during chronic morphine use may explain the decreasing pleasure (tolerance) and increasing distress that drives compulsive opioid use — the brain's own anti-reward system fighting back.
What This Study Doesn't Tell Us
Animal study in rats. Specific morphine dosing regimen may not represent all human opioid exposure patterns. Only measured peptide levels, not receptor changes.
Questions This Raises
- ?Do dynorphin increases in the nucleus accumbens directly drive the negative emotional state of opioid withdrawal?
- ?Could blocking dynorphin signaling reduce opioid dependence without affecting pain relief?
Trust & Context
- Key Stat:
- Dynorphin increased In the nucleus accumbens (reward center) after 8 days of chronic morphine, explaining tolerance development
- Evidence Grade:
- Moderate — controlled animal study with systematic measurement across brain regions, though limited to one dosing regimen.
- Study Age:
- Published in 1995. The dynorphin/anti-reward theory of addiction has since become a major framework in addiction neuroscience, substantially supported by subsequent research.
- Original Title:
- The effects of morphine treatment and morphine withdrawal on the dynorphin and enkephalin systems in Sprague-Dawley rats.
- Published In:
- Psychopharmacology, 118(4), 391-400 (1995)
- Authors:
- Nylander, I(10), Vlaskovska, M, Terenius, L(6)
- Database ID:
- RPEP-00337
Evidence Hierarchy
Tests effects in animals (usually mice or rats), not humans.
What do these levels mean? →Frequently Asked Questions
Why does morphine stop working as well over time?
Chronic morphine triggers the brain to increase dynorphin, its own anti-opioid peptide, in the reward center. This counteracts the morphine, requiring higher doses for the same effect — the core of tolerance.
What happens to these peptides during withdrawal?
The elevated dynorphin levels may persist during withdrawal while the external morphine is gone, leaving the anti-reward system unopposed. This imbalance contributes to the distress of opioid withdrawal.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-00337APA
Nylander, I; Vlaskovska, M; Terenius, L. (1995). The effects of morphine treatment and morphine withdrawal on the dynorphin and enkephalin systems in Sprague-Dawley rats.. Psychopharmacology, 118(4), 391-400.
MLA
Nylander, I, et al. "The effects of morphine treatment and morphine withdrawal on the dynorphin and enkephalin systems in Sprague-Dawley rats.." Psychopharmacology, 1995.
RethinkPeptides
RethinkPeptides Research Database. "The effects of morphine treatment and morphine withdrawal on..." RPEP-00337. Retrieved from https://rethinkpeptides.com/research/nylander-1995-the-effects-of-morphine
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.